BIOPHARMCATALYST Trademark
Serial Number: 90037875 • Registration: 6496435
Trademark Classes
Class 36 - Insurance & Financial
Insurance; financial affairs; monetary affairs; real estate affairs
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 35 - Advertising & Business
Advertising; business management; business administration; office functions
Owner Contact Info
Adam Burden Unit 5, 40 Old Red Barn Road
Halswell Christchurch 8025 , NZ
Entity Type: 99
Legal Representation
Correspondence Address
Pollie Gautsch, Esq. G&A LEGAL, APC
665 SAN RODOLFO 124-209
SOLANA BEACH, CA 92075
United States
Trademark Details
Filing Date
July 6, 2020
Registration Date
September 28, 2021
Published for Opposition
July 13, 2021
Goods & Services
Compiling indexes of information relevant to financial investment decisions
Providing stock market information; financial analysis and information services; financial analysis and information services, namely, providing information to investors about the timing of the results of clinical trials for pharmaceuticals to aid investors in making financial investment decisions; providing investors with financial information relevant to financial investment decisions; information, advisory, consultancy and research services relating to finance and investments; providing financial analysis of pharmaceutical companies listed on the U.S. stock market, for investment purposes; providing financial analysis of pharmaceutical companies listed on the U.S. stock market, for research purposes; providing investment information relating to pharmaceutical development; any of the aforementioned services when provided via a website or via a newsletter
Providing medical and scientific research information about the results of clinical trials for pharmaceuticals; analysis of technical pharmaceutical research data; provision of information and data relating to medical and veterinary research and development; providing information relating to pharmaceutical development including the results of clinical trials and pending clinical trial data of ongoing trials, for research purposes; any of the aforementioned services when provided via a website or via a newsletter
